Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXR NASDAQ:HIND NASDAQ:MDAI NASDAQ:QTEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.94+1.9%$10.20$8.45▼$14.76$54.06M0.272,222 shs1,303 shsHINDVyome$2.30+0.9%$2.17$1.75▼$18.60$16.14M1.4823,992 shs8,347 shsMDAISpectral AI$1.82-2.2%$2.03$1.18▼$3.21$57.92M1.151.07 million shs365,368 shsQTEXInspira Technologies OXY B.H.N.$1.29-15.1%$0.00$0.28▼$3.85$46.37M4.1176.66 million shs4.62 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor+1.36%-6.37%-3.44%-11.88%+13.65%HINDVyome+0.88%+6.48%+19.79%+2.22%+229,999,900.00%MDAISpectral AI-2.15%-3.70%-10.78%+37.88%-11.22%QTEXInspira Technologies OXY B.H.N.-15.13%-9.15%+128,999,900.00%+128,999,900.00%+128,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$9.94+1.9%$10.20$8.45▼$14.76$54.06M0.272,222 shs1,303 shsHINDVyome$2.30+0.9%$2.17$1.75▼$18.60$16.14M1.4823,992 shs8,347 shsMDAISpectral AI$1.82-2.2%$2.03$1.18▼$3.21$57.92M1.151.07 million shs365,368 shsQTEXInspira Technologies OXY B.H.N.$1.29-15.1%$0.00$0.28▼$3.85$46.37M4.1176.66 million shs4.62 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor+1.36%-6.37%-3.44%-11.88%+13.65%HINDVyome+0.88%+6.48%+19.79%+2.22%+229,999,900.00%MDAISpectral AI-2.15%-3.70%-10.78%+37.88%-11.22%QTEXInspira Technologies OXY B.H.N.-15.13%-9.15%+128,999,900.00%+128,999,900.00%+128,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxor 2.50Moderate BuyN/AN/AHINDVyome 2.40Hold$15.00552.17% UpsideMDAISpectral AI 2.00Hold$4.00119.78% UpsideQTEXInspira Technologies OXY B.H.N. 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest HIND, MDAI, DXR, and QTEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2026MDAISpectral AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/27/2026QTEXInspira Technologies OXY B.H.N. Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSell (E+)5/26/2026MDAISpectral AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$3.00 ➝ $4.005/21/2026MDAISpectral AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/6/2026MDAISpectral AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/6/2026HINDVyome Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/4/2026HINDVyome Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/1/2026HINDVyome Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)3/27/2026DXRDaxor Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)3/25/2026MDAISpectral AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.00(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxorN/AN/AN/AN/AN/AN/AHINDVyome$320K50.46N/AN/A$0.67 per share3.43MDAISpectral AI$19.65M2.95N/AN/A($0.19) per share-9.58QTEXInspira Technologies OXY B.H.N.$290K159.92N/AN/A$0.06 per share21.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/AN/AN/AN/AN/AN/AN/A8/20/2026 (Estimated)HINDVyome-$10.26M-$12.27N/AN/AN/A-270.58%-203.92%-134.16%N/AMDAISpectral AI-$7.57M-$0.53N/AN/AN/A-85.58%N/A-72.97%8/11/2026 (Estimated)QTEXInspira Technologies OXY B.H.N.-$13.22MN/AN/AN/AN/AN/AN/AN/AN/ALatest HIND, MDAI, DXR, and QTEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026HINDVyomeN/A-$0.15N/A-$0.15N/A$0.03 million5/12/2026Q1 2026MDAISpectral AI-$0.11-$0.11N/A-$0.11$4.13 million$3.99 million3/24/2026Q4 2025MDAISpectral AI-$0.1267$0.02+$0.1467$0.02$2.91 million$3.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxorN/AN/AN/AN/AN/AHINDVyomeN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/AQTEXInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AHINDVyomeN/A4.274.27MDAISpectral AIN/A0.750.71QTEXInspira Technologies OXY B.H.N.0.081.561.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%HINDVyome22.06%MDAISpectral AI67.08%QTEXInspira Technologies OXY B.H.N.12.72%Insider OwnershipCompanyInsider OwnershipDXRDaxor51.50%HINDVyome33.00%MDAISpectral AI13.70%QTEXInspira Technologies OXY B.H.N.29.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxor375.84 million2.83 millionNot OptionableHINDVyome507.02 million4.70 millionN/AMDAISpectral AI8331.82 million27.46 millionNot OptionableQTEXInspira Technologies OXY B.H.N.2035.95 million25.38 millionN/AHIND, MDAI, DXR, and QTEX HeadlinesRecent News About These CompaniesShort Interest in Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) Increases By 910.2%June 10 at 1:16 AM | americanbankingnews.comQTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum ComputingJune 9, 2026 | globenewswire.comQTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in BostonJune 2, 2026 | globenewswire.comQTREX Quantum (QTEX) Is Up 322.3% After $10M Private Placement And Nasdaq Rebrand – What's ChangedJune 2, 2026 | finance.yahoo.comQTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related MaterialsJune 1, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Investors Abandoned These 3 AI Stocks Too Early, Says Jeff ClarkBy Bridget Bennett | May 21, 2026Coke's $10B India IPO Plan Pops the Top on Hidden ValueBy Jeffrey Neal Johnson | June 3, 2026Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?By Jennifer Ryan Woods | May 19, 2026HIND, MDAI, DXR, and QTEX Company DescriptionsDaxor NASDAQ:DXR$9.94 +0.18 (+1.89%) Closing price 06/12/2026 03:50 PM EasternExtended Trading$9.85 -0.09 (-0.95%) As of 06/12/2026 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Vyome NASDAQ:HIND$2.30 +0.02 (+0.88%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$2.30 0.00 (0.00%) As of 06/12/2026 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.Spectral AI NASDAQ:MDAI$1.82 -0.04 (-2.15%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.84 +0.02 (+1.15%) As of 06/12/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Inspira Technologies OXY B.H.N. NASDAQ:QTEX$1.29 -0.23 (-15.13%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.34 +0.05 (+4.03%) As of 06/12/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears This Energy Stock Has Quietly Soared 130% in a Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
